Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ziyue Sha"'
Autor:
Xiaoyun Zhang, Shuo Xu, Jiaqi Wang, Yalei Lv, Na Wang, Ruixue Lai, Ziyue Sha, Qun Zhao, Zhanjun Guo
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Immune checkpoint inhibitors (ICIs) has shown remarkable benefit in the treatment of a range of cancer types, although it may initiate immune related adverse events (irAEs) in patients. Some studies have shown that there is a clos
Externí odkaz:
https://doaj.org/article/e3ef4da042f048b19236d0f970ac684c
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 17 (2023)
Background: Elevated level of interleukin-8 (IL-8) promotes hepatocellular carcinoma (HCC) development and contributes to poor prognosis. Previously, we have proved that Dicer inhibits HCC progression. In this study, we evaluated the potential intera
Externí odkaz:
https://doaj.org/article/8216cdc192cf499792aa690f48647fba
Publikováno v:
Hepatitis Monthly. 23
Background: Inflammatory cytokines are related to the occurrence and development of hepatocellular carcinoma (HCC). Objectives: Interleukin 6 (IL-6) is associated with the occurrence and prognosis of HCC, while Dicer inhibits HCC; accordingly, we che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41c3662f1f348cad435320015c05922b
https://doi.org/10.5812/hepatmon-134381
https://doi.org/10.5812/hepatmon-134381
Publikováno v:
DNA and Cell Biology. 39:1886-1894
Single nucleotide polymorphisms in miRNA binding sites (miR-SNPs) are associated with cancer risk. We assessed the relationship between five miR-SNPs in the 3′ untranslated region (3′-UTR) of RYR3 ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebaab7208f773d4f5e30de10c2755e5c
https://doi.org/10.1089/dna.2019.5179
https://doi.org/10.1089/dna.2019.5179
Publikováno v:
Journal of Hepatocellular Carcinoma
Cuiju Wang,1 Yalei Lv,2 Ziyue Sha,3 Jingjing Zhang,3 Jianhua Wu,4 Yixin Qi,5 Zhanjun Guo3 1Department of Gynaecology Ultrasound, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Peopleâs Republic of China; 2Department of Medical On
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f4e9d2e753b36ffbf979db392a92ba0
https://www.dovepress.com/dicer-enhances-bevacizumab-related-inhibition-of-hepatocellular-carcin-peer-reviewed-fulltext-article-JHC
https://www.dovepress.com/dicer-enhances-bevacizumab-related-inhibition-of-hepatocellular-carcin-peer-reviewed-fulltext-article-JHC